Shareholders Equity ratio Analysis of Eagle Pharmaceuticals Inc - Deep Dive


Shareholders Equity of EGRX
Dec-22
57.50
Good Shareholders Equity
Dec-21
69.54
Very Good Shareholders Equity
Growth
-17.31
%
Shareholders Equity Analysis of Eagle Pharmaceuticals Inc
Shareholders Equity Ratio of EGRX has fallen by -17.31 % Compared to previous Financial Year.
Shareholders Equity Ratio with value of 73.47 was highest in Year Dec-20 in last Five Years.
Shareholders Equity Ratio with value of 57.50 was lowest in Year Dec-22 in last Five Years.
Latest Shareholders Equity Ratio with value of 57.50 is lower than Average Shareholders Equity of 67.66 in last five years.
Other Shareholders Equity Related Info of EGRX that may interest you.
Eagle Pharmaceuticals Inc Overview
CodePricePrevious PricePrice ChangeSector
EGRX3.473.425 1.31 % Drug Manufacturers-Specialty & Generic
Fundamental AnalysisTechnical Analysis
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation.    more ..
Shareholders Equity Formula

Shareholders Equity Related Ratios
DebtToEquityRatioReturnOnEquity

Tsr Stability Index
Good Stability
FY - Historical Shareholders Equity of Eagle Pharmaceuticals Inc
PeriodDec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16
Shareholders Equity57.5069.5473.4770.3967.3866.3370.56
Change-17.31 %-5.34 %4.38 %4.47 %1.57 %-5.99 %-2.68 %
You are view first 7 Records. Log in to view all 11 in Premium view
FY Chart of Shareholders Equity of Eagle Pharmaceuticals Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)